Tag Cancer
Blood-based screen for colon cancer shows promise
The scientists expect their findings will ultimately lead to a blood test for the cancer, adding a method to help increase screening rates while reducing overtreatment.
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use anti-angiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
UW team finds key to common cancer pathway in discovery that could unlock new therapies
A team led by UW cancer researchers discovered an unexpected regulator of the critical protein p53, opening the door to the development of drugs that could target it.
Exploring the matrix to uncover hidden drivers of ovarian cancer
To clump together and form living tissue, cells secrete molecules that create structure. But that structure isn’t always healthy, and understanding how it goes bad could reveal more about the way cancer develops.
Nanoparticles improve tumor treatment in mice
In mouse models of human lung cancer, the improved drug inhibited tumor growth more effectively than the standard drug. “Ultimately, our goal is to get this into human beings,” says pharmacy professor Glen Kwon.
The Ride gets research into gear
The Ride is a signature cycling event that premiered in September 2016, sending hundreds of riders across eastern Dane County to raise money for cancer research on the UW–Madison campus.
Long-term cancer survivor beats odds, prompts study
The unusual case of Margaret “Peg” Geisler has inspired an international search for “extreme survivors” of metastatic breast cancer. “They never teach you about patients like Peg in medical school," says UW Health oncologist Mark Burkard.
Improved capture of cancer cells in blood could help track disease
By forcing cancer cells to slow down and developing stronger molecular traps specific to circulating tumor cells, researchers were able to identify large numbers of the cells in cancer patients undergoing radiation therapy.
3-D imaging of collagen may become vital tool for precision cancer treatment
Researcher Paul Campagnola has taken a crucial step toward creating 3-D images of collagen — the most abundant protein in humans, found in all of our bones, tendons and connective tissues — on a molecular scale.
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
Colleagues pay tribute to cancer researcher Patti Keely
It would be easy to simply say Patti Keely was a world-class, nationally recognized breast cancer researcher at the UW School of Medicine and Public…
Morgridge, UW researcher scores in cancer research ‘lightning round’
Scientists get funded for their ideas through a marathon grant-writing process, scores of collaborators, weeks of information gathering and a final product that often tops 250 pages. Melissa Skala’s experience was different: two people, 250 words, in 24 hours.
Wisconsin cancer patients test encouraging lymphoma treatment
Half of the patients in a Wisconsin Oncology Network clinical trial for a rare blood cancer are still in remission eight years after beginning treatment, according to new results of a follow-up to the study, led by UW hematologist Julie Chang.
OnLume receives SBIR support for image-guided surgery innovation
The novel technology was developed in collaboration with researchers at the Morgridge Institute for Research and UW–Madison.
Cancer signaling pathway could illuminate new avenue to therapy
The study could establish new avenues of therapeutic treatments for many types of solid tumors.
Alumnus’s startup seeks more precise screening for prostate cancer
Success will take years, but if the noninvasive screening test works, it could aid in early detection of a cancer that kills about 26,000 American men every year.
Smart cancer therapies: Teaching the body’s own T-cells to attack tumors
The therapies have already shown tremendous potential in treating blood-based cancers such as leukemia. Now, researchers are investigating ways to make them more versatile and practical.
Study links changes in collagen to worse pancreatic cancer prognosis
The study reinforces growing evidence that collagen, which forms fibrous networks in skin, tendons and muscles, is intimately involved in several cancers.
Madison startup advances three-in-one cancer drug rooted at UW
The first target for Co-D is angiosarcoma, a rare and lethal cancer that arises from blood vessels.
Tiny 3-D models may yield big insights into ovarian cancer
With a unique approach that draws on 3-D printing technologies, a team of UW–Madison researchers is developing new tools for understanding how ovarian cancer develops in women.